What You Should Know:
- Healthcare venture capital firm Longitude Capital announces the close of its $585M Longitude Venture Partners IV, L.P. (“LVP4”) fund to invest in transformative healthcare companies.
- LVP4 will invest opportunistically across all stages of
a company’s development through a variety of approaches that include
traditional venture capital investing and special situations such as spin-outs,
equity-linked transactions, and private investments in public
Read More
OurCrowd Launches $100M Pandemic Innovation Fund to Invest in Companies on Front Lines of COVID-19
What You Should Know:
- Israeli venture capital platform OurCrowd launches $100M Pandemic Fund to invest in companies on the front lines of COVID-19.
- The fund plans to raise $100M to invest in 15-20 companies focused on prevention & containment, treatment & healing, and community & disruption mitigation technology solutions to combat current and future pandemic.
OurCrowd,
a Jerusalem, Israel-based crowdfunded-venture investment platform, today
announced the launch
Read More
SV Health Investors Forms $90M Medtech Convergence Fund
What You Should Know:
- SV Health Investors forms $90M Medtech Convergence Fund (MCF) focused on the increasing convergence of medical technology with software, telecommunications, and new service models to create solutions to some of the most significant health challenges.
- MCF will focus on early-stage, novel device and technology solutions that are differentiated in usability and outcomes with meaningful barriers to entry through IP, design, and clinical data.
SV Health
Read More
Former FDA Commissioner Returns to Venture Capital Firm As Special Partner
Former FDA Commissioner Scott Gottlieb, M.D. is returning to global venture capital firm New Enterprise Associates (NEA) as a Special Partner on the firm’s healthcare investment team. Dr. Gottlieb was a Venture Partner at NEA from 2007 to 2017 before being appointed the 23rd Commissioner of the U.S. Food and Drug Administration (FDA), where he served from 2017 to 2019.Dr. Gottlieb is a physician, policy expert, and advocate for healthcare entrepreneurship, innovation, and access. He is focused
Read More
HealthQuest Capital Closes $440M Fund to Invest in Innovative Growth-Stage Companies
HealthQuest Capital, a Silicon Valley-based growth capital firm has closed a $440 million fund to invest growth-stage companies delivering innovation across all sectors of the healthcare industry to improve patient outcomes, enhance efficiency and reduce costs. Fund III was oversubscribed and closed at a hard cap. Target markets for Fund III include growth- and commercial-stage companies focusing on medical technologies, diagnostics, digital health, and innovative services.HealthQuest Capital
Read More
OSF Ventures Invests in LRVHealth’s $100M VC Fund as Limited Partner
OSF Ventures, the corporate investment arm of OSF HealthCare, is joining other health care systems and strategic investors from within the healthcare industry as a strategic limited partner (LP) in Boston-based LRVHealth's $100M "Inside Healthcare" venture capital fund. As part of LRVHealth’s collaborative innovation platform, OSF will help identify, create and invest in early-stage companies spanning healthcare IT, tech-enabled health services, medical devices, and diagnostics.
Why
Read More
HealthXCapital Launches $25M Early-Stage Digital Health VC Fund in SE Asia and India
Singapore-based venture capital firm HealthXCapital today announced the launch of its US$25 million digital health venture capital (VC) fund focused on emerging markets in South East Asia and India. The fund was backed by Apollo Hospitals, Jungle Ventures, Eight Roads Ventures (the proprietary investment arm of Fidelity International Limited), and other undisclosed private investors.HealthXCapital will focus on addressing: Access & Affordability — by investing in innovative healthcare
Read More
7wireVentures Launch $100M Connected Consumer Health Fund with Coalition of Healthcare Organizations
7wireVentures is an early stage healthcare venture firm based in Chicago has closed a $100 million fund and formed a coalition with eight healthcare provider and plans dedicated to investing in companies that use technology to help consumers get and stay healthy. The coalition of leading healthcare service organizations include Allina Health, Arkansas BlueCross BlueShield, Bon Secours Health System, Cigna, Horizon Blue Cross Blue Shield of New Jersey, Memorial Hermann Health System, Rush
Read More
SV Life Sciences Rebrands As SV Health Investors, Closes $400M Fund
Boston-based healthcare and life sciences venture capital and growth equity firm SV Life Sciences has changed its name to SV Health Investors and has closed its sixth flagship fund target of $400 million. SV Health Investors' venture partner program focuses on leveraging experienced healthcare entrepreneur to serve as hands-on advisors and directors for portfolio companies. This approach contributes to SV's appeal to both potential investors and entrepreneurs. The new multi-sector focus fund
Read More
The New Walking Dead: Why 98% of Health Tech Startups Are Zombies
Health investor and entrepreneur Dave Chase says 98 percent of health tech startups are zombies right now—but the Quadruple aim could help some rise from the ashes to begin anew.Billions in venture capital (VC) funding may have poured into digital health over the last few years (more than $4.5 billion in 2015 alone), but it looks like many startups may have bitten off more than they can chew, and as a result, imminently face biting the dust before reaching profitability. At least, that’s the
Read More
